VIAQUA THERAPEUTICS
ViAqua Therapeutics Ltd develops drugs and therapeutics for aquaculture. The company was founded in 2014 and is based in Israel.ViAqua Therapeutics is developing the first orally administered treatment for aquaculture.The Company’s management bring a broad range of business development, technology development, management, and industrial biotech experience.
VIAQUA THERAPEUTICS
Social Links:
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2014-01-01
Address:
Misgav, HaZafon, Israel
Country:
Israel
Website Url:
http://www.viaqua-t.com
Total Employee:
11+
Status:
Active
Contact:
+972.4.628.3014
Email Addresses:
[email protected]
Total Funding:
12.55 M USD
Technology used in webpage:
Google Google Cloud Shutterstock
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Brabant pharma
Brabant Pharma is in late-stage development of a treatment for Dravet Syndrome.
Semma Therapeutics
Semma Therapeutics was founded to develop transformative therapies for Type 1 diabetes patients.
Umthunzi
Umthunzi vrMarket is the first-of-its-kind global, clinical research ecosystem.
Current Advisors List
Current Employees Featured
Founder
Investors List
Agriline Ltd.
Agriline Ltd. investment in Venture Round - ViAqua Therapeutics
I-Lab Angels
I-Lab Angels investment in Venture Round - ViAqua Therapeutics
Trendlines Group
Trendlines Group investment in Venture Round - ViAqua Therapeutics
S2G Ventures
S2G Ventures investment in Venture Round - ViAqua Therapeutics
Circle Investments
Circle Investments investment in Venture Round - ViAqua Therapeutics
Nutreco
Nutreco investment in Venture Round - ViAqua Therapeutics
Rabo Ventures
Rabo Ventures investment in Venture Round - ViAqua Therapeutics
Israel Innovation Authority
Israel Innovation Authority investment in Grant - ViAqua Therapeutics
Thai Union Group
Thai Union Group investment in Venture Round - ViAqua Therapeutics
Clay Capital
Clay Capital investment in Venture Round - ViAqua Therapeutics
Official Site Inspections
http://www.viaqua-t.com
- Host name: 147.62.236.23.bc.googleusercontent.com
- IP address: 23.236.62.147
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "ViAqua Therapeutics"
ViAqua Therapeutics | Oral Delivery Platform Preventing …
The ViAqua delivery platform protects the RNA in the aquatic environment and withstands barriers in the digestive system to deliver the RNA. ViAqua is developing the first orally administered …See details»
ViAqua Therapeutics | About Us
ViAqua Therapeutics was established in September 2014 to address the growing need for effective, affordable health management of diseases in aquaculture.See details»
ViAqua Therapeutics | Technology Solution
ViAqua Therapeutics was established to address the growing need for effective, specific, and affordable health management of diseases in aquaculture. One of the major challenges facing …See details»
ViAqua Therapeutics secures funding for RNA-based …
Sep 6, 2023 · ViAqua Therapeutics, a biotechnology company and developer of an orally administered RNA-particle platform to promote and improve animal health in aquaculture, has completed a U.S. $8.25 million round led by S2G …See details»
ViAqua Therapeutics - Crunchbase Company Profile & Funding
ViAqua Therapeutics is developing the first orally administered treatment for aquaculture. ViAqua Therapeutics may be growing as it has successfully secured a significant investment of $8.25 …See details»
Combating Disease in Aquaculture with ViAqua - S2G
ViAqua Therapeutics is a biotechnology company that has developed a proprietary delivery method for RNA-based treatments to combat viral diseases in aquaculture. We are excited to announce our latest investment in ViAqua to …See details»
ViAqua Therapeutics LTD - LinkedIn
ViAqua Therapeutics LTD | 459 followers on LinkedIn. Aquaculture health enhancement | VIAQUA addresses the growing need for effective and affordable health management …See details»
ViAqua Therapeutics Announces $4.3 Million Investment led by …
MISGAV, Israel, June 9, 2021 /PRNewswire/ -- ViAqua Therapeutics, a biotechnology company and developer of an orally administered RNA-particle platform to promote and improve animal …See details»
ViAqua Therapeutics - The Trendlines Group
ViAqua has developed orally administered health management solution for aquaculture to improve resistance to viral diseases. ViAqua’s platform for improving resilience to viral diseases in …See details»
ViAqua Therapeutics Announces $4.3 Million ... - Aquaculture …
Jun 15, 2021 · ViAqua Therapeutics, a biotechnology company and developer of an orally administered RNA-particle platform to promote and improve animal health in aquaculture, …See details»
ViAqua Therapeutics - Craft
ViAqua Therapeutics is a company that develops an oral delivery platform preventing aquaculture diseases. Its orally administered particle-based platform is used for the administration of RNA …See details»
ViAqua Therapeutics | Landing page
ViAqua Therapeutics was established to address the growing need for effective, affordable treatments to combat diseases in aquaculture.See details»
ViAqua Therapeutics Announces $4.3 Million Investment led by …
MISGAV, Israel, June 9, 2021 /PRNewswire/ -- ViAqua Therapeutics, a biotechnology company and developer of an orally administered RNA-particle platform to promote and improve animal …See details»
ViAqua Therapeutics Announces $4.3 Million Investment led by …
Jun 9, 2021 · ViAqua is developing a biotechnology-based, oral delivery platform for administration of nucleic acid-based solutions for promoting health in marine species.See details»
ViAqua Therapeutics Company Profile 2024: Valuation, Funding ...
Developer of an orally administered particle-based platform designed to prevent diseases from developing viral epidemics in aquaculture.See details»
S2G Ventures backs several ocean and seafood companies
Jun 21, 2021 · ViAqua Therapeutics (https://www.viaqua-t.com) Founded in 2014 by Shai Ufaz and Shai Einbinder. Based in Israel, ViAqua is a biotechnology producer of an orally …See details»
ViAqua Therapeutics | Media
Jun 9, 2021 · ViAqua is developing the first orally-administered treatment for shrimp that improves resistance to viral diseases, including White Spot Syndrome Virus (WSSV), and prevents viral …See details»
Million dollar investment announced to scale RNA-based solutions …
Jan 2, 2024 · Biotechnology company, ViAqua Therapeutics announced the completion of a US$8.25mn investment led by S2G Ventures to scale RNA-based solutions in aquaculture.See details»
VIQUA Home Page - VIQUA
VIQUA is proud to be one of the world’s leading suppliers of residential and light commercial UV water treatment systems, providing treated water without the use of chemicals.See details»
ViAqua Therapeutics | Careers
If you enjoy solving problems, being part of a team, and are excited about furthering the develop of our innovative oral drug delivery platform, ViAqua may be the place for you. For more …See details»